China National Medicines Corporation Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | The predecessor of China National Pharmaceutical Group Pharmaceutical Co., Ltd. was China Pharmaceutical Corporation. It was initiated and established by China National Pharmaceutical Group Corporation on December 21, 1999, and was successfully listed on the Shanghai Stock Exchange in 2002. China National Pharmaceutical Group Pharmaceutical Co., Ltd. is a Fortune 500 enterprise. Sinopharm Corporation, adhering to the glorious tradition of its predecessor, the Chinese pharmaceutical company, for over half a century, is an important component of the national disease prevention and control system! Received high praise from government departments such as the National Development and Reform Commission and the Ministry of Health in the battles against SARS, earthquake relief, and H1N1 influenza prevention and control!. |
| Headquarter | Beijing |
| Establish Date | 12/21/1999 |
| Listed Code | 600511.SH |
| Listed Date | 11/27/2002 |
| Chairman | Jiang Xiuchang. |
| CEO | Tian Guotao. |
| Website | www.cncm.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
